Focus on Increasing Awareness
and Enhancing Stockholder Value
Miami, FL -- November 30, 2021 -- InvestorsHub NewsWire
-- Progressive Care, Inc. (OTCQB:
RXMD) (the “Company”), a personalized healthcare services and
technology provider, today announced that it has retained
ClearThink Capital (“ClearThink”), a strategic advisory firm, to
develop and deploy a comprehensive investor outreach and
communications program.
“We believe we are now ready to enter the next growth phase of
our business, as we recently filed our S-1 Registration Statement
in order to become fully reporting and compliant with the U.S.
Securities and Exchange Commission and as part of our plan to
become listed on Nasdaq,” stated Alan Jay Weisberg, Chairman and
Chief Executive Officer of Progressive Care.
Weisberg continued, “Our mission to improve every step of the
patient journey by adding value to prescribers, caregivers, and
patients in a seamless manner has led us to growth in revenue,
improved margins and an improvement in the company’s overall cash
flow. We hired The Benchmark Company to lead our capital markets
initiative to uplist to Nasdaq. As we look to this positive
momentum, our Board and management believe it is an appropriate
time to retain a proactive strategic investor relations firm to
help us reach new potential investors and effectively communicate
our investment thesis. We are confident that ClearThink will help
us convey our strategy, business objectives and corporate
milestones to a wider audience of sophisticated investors and
improve our visibility and awareness.”
Brian Loper, Senior VP and Account Manager of ClearThink,
commented, “With its unique model for pharmacy operation and data
management, SaaS-based revenue streams, digital health
technologies, expanded penetration of its PharmCo-branded
operations, improved financials and clear path in becoming SEC
reporting, we believe Progressive Care’s investment proposition is
compelling, and the ClearThink team is eager to elevate the
company's IR efforts. These efforts will include implementing a
comprehensive targeting strategy to communicate a clearer and more
concise message to an expanded audience of relevant investors that
we expect, over time, should help unlock and drive stockholder
value.”
ClearThink is a consulting firm known for its ability to connect
underfollowed and undervalued smaller reporting companies with
sophisticated institutional investors, buy-side and sell-side
analysts, retail brokerage firms and accredited individual
investors. Leveraging decades of cumulative experience, ClearThink
develops strategies to help clients effectively communicate with
the investment community and works to increase their exposure
through targeted outreach and transparent positioning. ClearThink
helps public companies deliver the right message to the right
audience. Over time, ClearThink helps its clients navigate up the
Wall Street value chain and to help them secure a reasonable
valuation by broadening their audience, expanding institutional
ownership and ensuring clear, consistent communication with the
public.
About Progressive Care:
Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of Third-Party Administration (TPA), data
management, COVID-19 related diagnostics and vaccinations, 340B
contracted pharmacy services, prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/ https://twitter.com/ProgressCareUS
PharmCoRx
https://www.pharmcorx.com/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
Forward-Looking Statements:
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
When used herein, the words “anticipate,” “believe,” “estimate,”
“upcoming,” “plan,” “target,” “intend” and “expect” and similar
expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company’s actual results, performance, prospects,
and opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Investor Relations Contact:
Brian Loper
ClearThink
bloper@clearthink.capital
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2024 to May 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From May 2023 to May 2024